Follow
Kim Ravnskjaer
Title
Cited by
Cited by
Year
A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange
Y Liu, R Dentin, D Chen, S Hedrick, K Ravnskjaer, S Schenk, J Milne, ...
Nature 456 (7219), 269-273, 2008
6272008
Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis
MM Mihaylova, DS Vasquez, K Ravnskjaer, PD Denechaud, TY Ruth, ...
Cell 145 (4), 607-621, 2011
5982011
Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression
K Ravnskjaer, H Kester, Y Liu, X Zhang, D Lee, JR Yates III, M Montminy
The EMBO journal 26 (12), 2880-2889, 2007
1972007
Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity
Y Wang, H Inoue, K Ravnskjaer, K Viste, N Miller, Y Liu, S Hedrick, L Vera, ...
Proceedings of the National Academy of Sciences 107 (7), 3087-3092, 2010
1782010
Peroxisome proliferator-activated receptor α (PPARα) potentiates, whereas PPARγ attenuates, glucose-stimulated insulin secretion in pancreatic β-cells
K Ravnskjaer, M Boergesen, B Rubi, JK Larsen, T Nielsen, J Fridriksson, ...
Endocrinology 146 (8), 3266-3276, 2005
1302005
Role of the cAMP pathway in glucose and lipid metabolism
K Ravnskjaer, A Madiraju, M Montminy
Metabolic Control, 29-49, 2016
1152016
PPARδ is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction
K Ravnskjaer, F Frigerio, M Boergesen, T Nielsen, P Maechler, ...
Journal of lipid research 51 (6), 1370-1379, 2010
1112010
Glucose-induced repression of PPARalpha gene expression in pancreatic beta-cells involves PP2A activation and AMPK inactivation
K Ravnskjaer, M Boergesen, LT Dalgaard, S Mandrup
Journal of molecular endocrinology 36 (2), 289, 2006
1082006
Pancreatic β-cell lipotoxicity induced by overexpression of hormone-sensitive lipase
M Sörhede Winzell, H Svensson, S Enerbäck, K Ravnskjaer, ...
Diabetes 52 (8), 2057-2065, 2003
902003
Glucagon regulates gluconeogenesis through KAT2B-and WDR5-mediated epigenetic effects
K Ravnskjaer, MF Hogan, D Lackey, L Tora, SYR Dent, J Olefsky, ...
The Journal of clinical investigation 123 (10), 4318-4328, 2013
842013
Transcriptional regulation of Hepatic Stellate Cell activation in NASH
AB Marcher, SM Bendixen, MK Terkelsen, SS Hohmann, MH Hansen, ...
Scientific reports 9 (1), 2324, 2019
782019
Transcriptional dynamics of hepatic sinusoid‐associated cells after liver injury
MK Terkelsen, SM Bendixen, D Hansen, EAH Scott, AF Moeller, ...
Hepatology 72 (6), 2119-2133, 2020
762020
Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication
A Loft, AJ Alfaro, SF Schmidt, FB Pedersen, MK Terkelsen, M Puglia, ...
Cell metabolism 33 (8), 1685-1700. e9, 2021
752021
Peroxisome proliferator-activated receptor α (PPARα) protects against oleate-induced INS-1E beta cell dysfunction by preserving carbohydrate metabolism
F Frigerio, T Brun, C Bartley, A Usardi, D Bosco, K Ravnskjaer, S Mandrup, ...
Diabetologia 53, 331-340, 2010
502010
Hepatic insulin resistance following chronic activation of the CREB coactivator CRTC2
MF Hogan, K Ravnskjaer, S Matsumura, MO Huising, RL Hull, SE Kahn, ...
Journal of Biological Chemistry 290 (43), 25997-26006, 2015
352015
Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness
VI Chandran, CW Wernberg, MM Lauridsen, MK Skytthe, SM Bendixen, ...
Hepatology 77 (2), 558-572, 2023
212023
Osteoprotegerin is more than a possible serum marker in liver fibrosis: A study into its function in human and murine liver
A Adhyatmika, L Beljaars, KSS Putri, H Habibie, CE Boorsma, ...
Pharmaceutics 12 (5), 471, 2020
212020
The transcription factor ATF3 switches cell death from apoptosis to necroptosis in hepatic steatosis in male mice
Y Inaba, E Hashiuchi, H Watanabe, K Kimura, Y Oshima, K Tsuchiya, ...
Nature Communications 14 (1), 167, 2023
132023
Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis
M Bobowski-Gerard, C Boulet, FP Zummo, J Dubois-Chevalier, ...
Nature Communications 13 (1), 5324, 2022
122022
The role of diagnostic biomarkers, omics strategies, and single-cell sequencing for nonalcoholic fatty liver disease in severely obese patients
CW Wernberg, K Ravnskjaer, MM Lauridsen, M Thiele
Journal of Clinical Medicine 10 (5), 930, 2021
72021
The system can't perform the operation now. Try again later.
Articles 1–20